Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Management of patients with multidrug-resistant tuberculosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. A new health care index predicts short term mortality for TB and HIV co-infected people

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Diabetes-related tuberculosis in Denmark: effect of ethnicity, diabetes duration and year of diagnosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Chronic bronchitis: so much more than just a smoker's cough

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Can tuberculosis case finding among health-care seeking adults be improved? Observations from Bissau

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A new health care index predicts short term mortality for TB and HIV co-infected people

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • C Lange
  • R E Aarnoutse
  • J W C Alffenaar
  • G Bothamley
  • F Brinkmann
  • J Costa
  • D Chesov
  • R van Crevel
  • M Dedicoat
  • J Dominguez
  • R Duarte
  • H P Grobbel
  • G Günther
  • L Guglielmetti
  • J Heyckendorf
  • A W Kay
  • O Kirakosyan
  • O Kirk
  • R A Koczulla
  • G G Kudriashov
  • L Kuksa
  • F van Leth
  • C Magis-Escurra
  • A M Mandalakas
  • B Molina-Moya
  • C A Peloquin
  • M Reimann
  • R Rumetshofer
  • H S Schaaf
  • T Schön
  • S Tiberi
  • J Valda
  • P K Yablonskii
  • K Dheda
Vis graf over relationer

The emergence of multidrug-resistant tuberculosis (MDR-TB; defined as resistance to at least rifampicin and isoniazid) represents a growing threat to public health and economic growth. Never before in the history of mankind have more patients been affected by MDR-TB than is the case today. The World Health Organization reports that MDR-TB outcomes are poor despite staggeringly high management costs. Moreover, treatment is prolonged, adverse events are common, and the majority of affected patients do not receive adequate treatment. As MDR-TB strains are often resistant to one or more second-line anti-TB drugs, in-depth genotypic and phenotypic drug susceptibility testing is needed to construct personalised treatment regimens to improve treatment outcomes. For the first time in decades, the availability of novel drugs such as bedaquiline allow us to design potent and well-tolerated personalised MDR-TB treatment regimens based solely on oral drugs. In this article, we present management guidance to optimise the diagnosis, algorithm-based treatment, drug dosing and therapeutic drug monitoring, and the management of adverse events and comorbidities, associated with MDR-TB. We also discuss the role of surgery, physiotherapy, rehabilitation, palliative care and smoking cessation in patients with MDR-TB. We hope that incorporating these recommendations into patient care will be helpful in optimising treatment outcomes, and lead to more MDR-TB patients achieving a relapse-free cure.

OriginalsprogEngelsk
TidsskriftThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Vol/bind23
Udgave nummer6
Sider (fra-til)645-662
Antal sider18
ISSN1027-3719
DOI
StatusUdgivet - 1 jun. 2019

ID: 59238545